Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001362310-09-003391
Filing Date
2009-03-09
Accepted
2009-03-06 18:13:18
Documents
10
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c80645e10vk.htm 10-K 776750
2 EXHIBIT 10.36 c80645exv10w36.htm EX-10.36 142758
3 EXHIBIT 23.1 c80645exv23w1.htm EX-23.1 1425
4 EXHIBIT 23.2 c80645exv23w2.htm EX-23.2 1412
5 EXHIBIT 31.1 c80645exv31w1.htm EX-31.1 5503
6 EXHIBIT 31.2 c80645exv31w2.htm EX-31.2 5451
7 EXHIBIT 32 c80645exv32.htm EX-32 3131
8 GRAPHIC c80645c8064500.gif GRAPHIC 2493
9 GRAPHIC c80645c8064501.gif GRAPHIC 815
10 GRAPHIC c80645c8064502.gif GRAPHIC 21046
  Complete submission text file 0001362310-09-003391.txt   971868
Mailing Address 1730 EAST RIVER ROAD SUITE 200 TUSCON AZ 85718
Business Address 1730 EAST RIVER ROAD SUITE 200 TUSCON AZ 85718 520-770-1259
IMARX THERAPEUTICS INC (Filer) CIK: 0001123695 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33043 | Film No.: 09664390
SIC: 2834 Pharmaceutical Preparations